Valuation
Pharmaceutical PreparationsLive · Yahoo FinancePrice
$1129.35
52-Week Range
Decision Context
Outperforms sector peers on capital efficiency. The peer comparison edge is a meaningful differentiator in the current competitive landscape.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.64%
Accommodative
10-Year Treasury
4.25%
2026-03-01
Unemployment
4.3%
Near full employment
CPI Index
330.3
2026-03-01
M2 Money Supply
$22.7T
2026-03-01
The Federal Funds rate stands at 3.64% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.25%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.3%; Industrial production index is at 101.8; M2 money supply is $22.7T; CPI index stands at 330.3.
SWOT Analysis — LLY
Inflationary BoomStrengths
EPS (Diluted): $22.95 (+96.0% YoY) — Earnings per share rose 96% — each share earned more.
Net Income: $20.6B (+94.9% YoY) — Profit grew 95% — the company kept more of each dollar earned.
Operating Cash Flow: $16.8B (+90.7% YoY) — Operating cash flow grew 91% — the business generated more cash from day-to-day operations.
Revenue: $65.2B (+44.7% YoY) — Revenue grew 45% — the company sold more goods or services than the prior year.
Total Assets: $112.5B (+42.9% YoY) — Total assets grew 43% — the company's resource base expanded.
Weaknesses
No material weaknesses flagged.
Opportunities
No clear opportunities identified at this time.
Threats
No significant threats flagged.
Financial Charts
Revenue vs Net Income
Margin Trend
Operating Cash Flow
Year-over-Year Changes
EPS (Diluted)
$22.95
was $11.71
Earnings per share rose 96% — each share earned more.
Net Income
$20.6B
was $10.6B
Profit grew 95% — the company kept more of each dollar earned.
Operating Cash Flow
$16.8B
was $8.8B
Operating cash flow grew 91% — the business generated more cash from day-to-day operations.
Revenue
$65.2B
was $45.0B
Revenue grew 45% — the company sold more goods or services than the prior year.
Total Assets
$112.5B
was $78.7B
Total assets grew 43% — the company's resource base expanded.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubFiling History — LLY
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade LLY
Links open broker research pages. Not an endorsement or recommendation.
Research ELI LILLY AND COMPANY
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.